Bepridil

Bepridil
Clinical data
Trade names	Vascor
AHFS/Drugs.com	Monograph
MedlinePlus	a699051
Routes of; administration	Oral
ATC code	C08EA02 (WHO) ;
Pharmacokinetic data
Bioavailability	Well absorbed
Protein binding	99%
Metabolism	Hepatic, CYP3A4-mediated
Elimination half-life	42 hours
Excretion	Renal
Identifiers
	IUPAC name N-benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline;
CAS Number	64706-54-3 ;
PubChem CID	2351;
IUPHAR/BPS	2337;
DrugBank	DB01244 ;
ChemSpider	2261 ;
UNII	755BO701MA;
ChEBI	CHEBI:3061 ;
ChEMBL	ChEMBL1008 ;
CompTox Dashboard (EPA)	DTXSID3022663 ;
Chemical and physical data
Formula	C24H34N2O
Molar mass	366.549 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O(CC(C)C)CC(N1CCCC1)CN(c2ccccc2)Cc3ccccc3;
	InChI InChI=1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3 ; Key:UIEATEWHFDRYRU-UHFFFAOYSA-N ;
	(verify)

Bepridil (trade name Vascor) is an amine calcium channel blocker once used to treat angina. It is no longer sold in the United States.

It is nonselective.[1]

It has been discussed as a possible option in the treatment of atrial fibrillation.[2]

It has been implicated in causing ventricular arrhythmia (torsades de pointes).

Ebola research

In June 2015 a research paper [3] was published finding bepridil to result in a 100% survival rate for mice exposed to ebola during an experiment searching for potential pharmaceutical ebola treatments; indicating its potential use in future ebola research and therapy.[4]

References

Bezprozvanny I, Tsien RW (September 1995). "Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967)". Mol. Pharmacol. 48 (3): 540–9. PMID 7565636.
Imai S, Saito F, Takase H, et al. (May 2008). "Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm". Circ. J. 72 (5): 709–15. doi:10.1253/circj.72.709. PMID 18441448.
Johansen, Lisa M.; Dewald, Lisa Evans; Shoemaker, Charles J.; Hoffstrom, Benjamin G.; Lear-Rooney, Calli M.; Stossel, Andrea; Nelson, Elizabeth; Delos, Sue E.; Simmons, James A.; Grenier, Jill M.; Pierce, Laura T.; Pajouhesh, Hassan; Lehár, Joseph; Hensley, Lisa E.; Glass, Pamela J.; White, Judith M.; Olinger, Gene G. (2015). "A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity". Science Translational Medicine. 7 (290): 290ra89. doi:10.1126/scitranslmed.aaa5597. PMID 26041706.
"Zoloft as Ebola cure? Antidepressant is one of a number of promising drugs being looked at by scientists".

External links

MedlinePlus DrugInfo medmaster-a697050

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[pmid7565636-1] Bezprozvanny I, Tsien RW (September 1995). "Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967)". Mol. Pharmacol. 48 (3): 540–9. PMID 7565636.

[pmid18441448-2] Imai S, Saito F, Takase H, et al. (May 2008). "Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm". Circ. J. 72 (5): 709–15. doi:10.1253/circj.72.709. PMID 18441448.

[3] Johansen, Lisa M.; Dewald, Lisa Evans; Shoemaker, Charles J.; Hoffstrom, Benjamin G.; Lear-Rooney, Calli M.; Stossel, Andrea; Nelson, Elizabeth; Delos, Sue E.; Simmons, James A.; Grenier, Jill M.; Pierce, Laura T.; Pajouhesh, Hassan; Lehár, Joseph; Hensley, Lisa E.; Glass, Pamela J.; White, Judith M.; Olinger, Gene G. (2015). "A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity". Science Translational Medicine. 7 (290): 290ra89. doi:10.1126/scitranslmed.aaa5597. PMID 26041706.

[4] "Zoloft as Ebola cure? Antidepressant is one of a number of promising drugs being looked at by scientists".